SouthState’s Krystal Biotech KRYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-2
Closed -$744 – 1410
2026
Q2
$744 Buy
+2
New +$598 ﹤0.01% 1162

Other funds holding KRYS

SouthState's KRYS Position: Q3 2026 in Review

SouthState sold out of Krystal Biotech (KRYS) in Q3 2026, closing a stake of 2 shares — an estimated $744 sold.

SouthState first reported a position in KRYS in Q2 2026 and held it in 1 quarter. The position peaked at $744 in Q2 2026. 353 funds tracked by Wall St. Rank hold KRYS as of Q3 2026.

  • SouthState reported no remaining Krystal Biotech position as of Q3 2026 after selling out during the quarter.
  • SouthState sold 2 Krystal Biotech shares in Q3 2026, an estimated $744.
  • SouthState first reported a position in Krystal Biotech in Q2 2026 and held it in 1 quarter.
  • SouthState's Krystal Biotech position peaked at $744 in Q2 2026.
  • 353 funds tracked by Wall St. Rank held Krystal Biotech as of Q3 2026.

Based on SouthState's 13F filing for Q3 2026, filed 9 Nov 2026.